Page last updated: 2024-09-03

ezogabine and Degenerative Diseases, Central Nervous System

ezogabine has been researched along with Degenerative Diseases, Central Nervous System in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Ito, D; Morimoto, S; Nakahara, J; Okada, K; Okano, H; Takahashi, S1
Kato, C; Morimoto, S; Nakahara, J; Okano, H; Takahashi, S1
Mora, G; Tapia, R1

Reviews

1 review(s) available for ezogabine and Degenerative Diseases, Central Nervous System

ArticleYear
Induced pluripotent stem cells-based disease modeling, drug screening, clinical trials, and reverse translational research for amyotrophic lateral sclerosis.
    Journal of neurochemistry, 2023, Volume: 167, Issue:5

    Topics: Amyotrophic Lateral Sclerosis; Drug Evaluation, Preclinical; Humans; Induced Pluripotent Stem Cells; Neurodegenerative Diseases; Randomized Controlled Trials as Topic; Translational Research, Biomedical

2023

Trials

1 trial(s) available for ezogabine and Degenerative Diseases, Central Nervous System

ArticleYear
Maiden voyage: induced pluripotent stem cell-based drug screening for amyotrophic lateral sclerosis.
    Brain : a journal of neurology, 2023, 01-05, Volume: 146, Issue:1

    Topics: Amyotrophic Lateral Sclerosis; Animals; Drug Evaluation, Preclinical; Induced Pluripotent Stem Cells; Neurodegenerative Diseases; Reproducibility of Results

2023

Other Studies

1 other study(ies) available for ezogabine and Degenerative Diseases, Central Nervous System

ArticleYear
Effects of retigabine on the neurodegeneration and extracellular glutamate changes induced by 4-aminopyridine in rat hippocampus in vivo.
    Neurochemical research, 2005, Volume: 30, Issue:12

    Topics: 4-Aminopyridine; Animals; Anticonvulsants; Carbamates; Drug Interactions; Electroencephalography; Extracellular Space; Glutamic Acid; Hippocampus; Male; Microdialysis; Neurodegenerative Diseases; Phenylenediamines; Rats; Rats, Wistar

2005